Publication:
Recommendations for follow-up of colorectal cancer survivors

Simple item page
dc.contributor.authorVera, R
dc.contributor.authorAparicio, J
dc.contributor.authorCarballo, F
dc.contributor.authorEsteva, Magdalena
dc.contributor.authorGonzalez-Flores, E
dc.contributor.authorSantianes, J
dc.contributor.authorSantolaya, F
dc.contributor.authorFernandez-Cebrian, JM
dc.date.accessioned2024-09-10T13:10:34Z
dc.date.available2024-09-10T13:10:34Z
dc.date.issued2019-10
dc.description.abstractColorectal cancer (CRC) is one of the tumours with the highest incidence and mortality in the Spanish population. Nevertheless, the advances in prevention and treatment have contributed to an increased number of patients who survive for prolonged periods of time. In addition, despite recurrences, improved survival following metastasis resection is likewise on the rise. This underscores the importance of carrying out follow-up programmes even in low-risk patients for the early detection of recurrence. The main objective of this article is to provide a set of recommendations for optimising the follow-up of CRC survivors as well as for managing the sequelae that result from either pharmacological or surgical treatment.en
dc.description.sponsorshipThis project was supported with an unrestricted grant from SEOM.es_ES
dc.format.number10es_ES
dc.format.page1302-1311es_ES
dc.format.volume21es_ES
dc.identifier.citationVera R, Aparicio J, Carballo F, Esteva M, Gonzalez-Flores E, Santianes J, et al. Recommendations for follow-up of colorectal cancer survivors. Clin Transl Oncol. 2019 Oct;21(10):1302-11. Epub 2019 Feb 14.en
dc.identifier.doi10.1007/s12094-019-02059-1
dc.identifier.e-issn1699-3055es_ES
dc.identifier.issn1699-048X
dc.identifier.journalClinical & Translational Oncologyes_ES
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/14687
dc.identifier.pubmedID30762206es_ES
dc.identifier.puiL626412990
dc.identifier.scopus2-s2.0-85061628879
dc.identifier.urihttps://hdl.handle.net/20.500.12105/22813
dc.identifier.wos486535700002
dc.language.isoengen
dc.publisherSpringer
dc.relation.publisherversionhttps://dx.doi.org/10.1007/s12094-019-02059-1en
dc.rights.accessRightsopen accessen
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCancer survivors
dc.subjectTreatment sequelae
dc.subjectQuality of life
dc.subjectSurveillance
dc.subjectMonitoring
dc.subjectCare coordination
dc.subject.decsComplicaciones Posoperatorias*
dc.subject.decsSupervivientes de Cáncer*
dc.subject.decsFactores de Tiempo*
dc.subject.decsFemenino*
dc.subject.decsNeoplasias Hepáticas*
dc.subject.decsEstadificación de Neoplasias*
dc.subject.decsNeoplasias Pulmonares*
dc.subject.decsRecurrencia Local de Neoplasia*
dc.subject.decsAntígeno Carcinoembrionario*
dc.subject.decsMasculino*
dc.subject.decsContinuidad de la Atención al Paciente*
dc.subject.decsColonoscopía:*
dc.subject.decsNeoplasias del Colon*
dc.subject.decsRadioterapia*
dc.subject.decsPrevención Secundaria*
dc.subject.decsAntineoplásicos*
dc.subject.decsGrupo de Atención al Paciente*
dc.subject.decsDisfunciones Sexuales Fisiológicas*
dc.subject.decsHumanos*
dc.subject.decsVigilancia de la Población*
dc.subject.decsPrevención Primaria*
dc.subject.decsNeoplasias del Recto*
dc.subject.decsOxaliplatino*
dc.subject.meshColonoscopy*
dc.subject.meshHumans*
dc.subject.meshOxaliplatin*
dc.subject.meshAntineoplastic Agents*
dc.subject.meshColonic Neoplasms*
dc.subject.meshContinuity of Patient Care*
dc.subject.meshNeoplasm Staging*
dc.subject.meshPopulation Surveillance*
dc.subject.meshLiver Neoplasms*
dc.subject.meshMale*
dc.subject.meshCarcinoembryonic Antigen*
dc.subject.meshNeoplasm Recurrence, Local*
dc.subject.meshTime Factors*
dc.subject.meshRadiotherapy*
dc.subject.meshLung Neoplasms*
dc.subject.meshPatient Care Team*
dc.subject.meshFemale*
dc.subject.meshSexual Dysfunction, Physiological*
dc.subject.meshCancer Survivors*
dc.subject.meshPostoperative Complications*
dc.subject.meshRectal Neoplasms*
dc.subject.meshPrimary Prevention*
dc.subject.meshSecondary Prevention*
dc.titleRecommendations for follow-up of colorectal cancer survivorsen
dc.typeresearch articleen
dspace.entity.typePublication
relation.isPublisherOfPublication8d558850-2ef2-4d1e-b0e1-4e5591ab6288
relation.isPublisherOfPublication.latestForDiscovery8d558850-2ef2-4d1e-b0e1-4e5591ab6288

Files

Collections

IdisBa - Instituto de Investigación Sanitaria Illes Balears (Baleares)
IMIB - Instituto Murciano de Investigación Biosanitaria Pascual Parrilla (Murcia)